ECA
MRK icon

Elevate Capital Advisors’s Merck MRK Stock Holding History

Elevate Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Sell
9,287
-655
-7% -$76.7K 0.66% 37
2026
Q1 		$1.2M Sell
9,942
-1,691
-15% -$195K 0.77% 39
2025
Q4 		$1.22M Buy
11,633
+2,988
+35% +$280K 0.81% 44
2025
Q3 		$726K Buy
+8,645
New +$712K 0.51% 54

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Elevate Capital Advisors's MRK Position: Q2 2026 in Review

Elevate Capital Advisors reduced its Merck (MRK) stake by 6.6% in Q2 2026, selling an estimated $76.7K and leaving 9,287 shares worth $1.19M. The position accounts for 0.66% of the portfolio, ranked #37.

Elevate Capital Advisors first reported a position in MRK in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.22M in Q4 2025. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Elevate Capital Advisors held 9,287 shares of Merck worth $1.19M as of Q2 2026.
  • Elevate Capital Advisors sold 655 Merck shares in Q2 2026, an estimated $76.7K.
  • Merck made up 0.66% of Elevate Capital Advisors's portfolio in Q2 2026, its #37 holding.
  • Elevate Capital Advisors first reported a position in Merck in Q3 2025 and has held it in 4 quarters since.
  • Elevate Capital Advisors's Merck position peaked at $1.22M in Q4 2025.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Elevate Capital Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.